- Home
- KNSA vs TAC Comparison
KNSA vs TAC Comparison
Compare KNSA & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | TAC |
|---|---|---|
| Founded | 2015 | 1909 |
| Country | United Kingdom | Canada |
| Employees | N/A | 1350 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KNSA | TAC |
|---|---|---|
| Price | $43.08 | $12.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $56.00 | $23.67 |
| AVG Volume (30 Days) | 530.4K | ★ 1.0M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.49% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.60 | N/A |
| Revenue Next Year | $17.77 | $6.48 |
| P/E Ratio | $59.87 | ★ N/A |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $19.62 | $8.34 |
| 52 Week High | $50.03 | $17.88 |
Technical Indicators
Market Signals| Indicator | KNSA | TAC |
|---|---|---|
| Relative Strength Index (RSI) | 35.32 | 41.18 |
| Support Level | $39.96 | $12.59 |
| Resistance Level | $46.93 | $12.69 |
| Average True Range (ATR) | 1.99 | 0.41 |
| MACD | -0.51 | -0.08 |
| Stochastic Oscillator | 6.73 | 5.88 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse electrical power generation assets in Canada, the United States, and Western Australia. The company has reportable segments namely, Hydro, Wind & Solar, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.